Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 7
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort ascending | Purpose |
---|---|---|---|---|---|---|
Filariasis and transfusion-associated risk: a literature review | Drews SJ, Spencer BR, Wendel S, Bloch EM, International Society of Blood Transfusion TTID Working Party Parasite Subgroup | 2021 | Vox Sang | View Filariasis and transfusion-associated risk: a literature review | Health care providers | Clinical research |
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima K, Speedy J, Bruun M, Dunbar N | 2021 | Vox Sang | View Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Health care providers | Benchmarking and standard setting |
ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Modi D | 2021 | Blood.ca website | View ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Health care providers | Clinical research |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Al-Riyami AZ, Estcourt L, Rahimi-Levene N, Bloch EM, Goel R, Tiberghien P, Thibert J-B, Bruun MT, Devine DV, Gammon RR, Wendel S, Toungouz Nevessignsky M, Grubovic Rastvorceva RM, Oreh A, Romon I, van den Berg K, Kitazawa J, Patidar G, So-Osman C, Wood EM, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management | Mahamad S, Modi D, Al-Samkari H, Cuker A, Despotovic JM, Italiano JE, Lambert MP, Lee EJ, Rondina MT, Sholzberg M, Kruse C, Larché M, Nazy I, Miller MS, Arnold DM | 2023 | Res Pract Thromb Haemost | View Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management | Health care providers | Clinical research |
Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Peng HT, Rhind SG, Moes K, Devine D, Jenkins C, Beckett A | 2022 | Transfusion | View Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Health care providers | New or improved product or process |
Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH | 2018 | Transfusion | View Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Don autologue préopératoire | Pambrun C | 2017 | Guide de la pratique transfusionnelle | View Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
Hemoglobin Area and Time Index Above 90 g/L are Associated with Improved 6-Month Functional Outcomes in Patients with Severe Traumatic Brain Injury | Griesdale DE, Sekhon MS, Menon DK, Lavinio A, Donnelly J, Robba C, Sekhon IS, Taylor A, Henderson WR, Turgeon AF, Gupta AK | 2014 | Neurocrit Care | View Hemoglobin Area and Time Index Above 90 g/L are Associated with Improved 6-Month Functional Outcomes in Patients with Severe Traumatic Brain Injury | Health care providers | Clinical research |
Immune thrombocytopenia: getting back to basics | Arnold DM | 2012 | Am J Hematol | View Immune thrombocytopenia: getting back to basics | Health care providers | Other |
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG | 2017 | Blood Adv | View Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Health care providers | Clinical research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Health care providers | New or improved product or process |
Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review | Shih AW, Sheppard JI, Warkentin TE | 2017 | Thromb Haemost | View Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review | Health care providers | Clinical research |
Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections | Talreja H, Akbari A, White CA, Ramsay TO, Hiremath S, Knoll G | 2014 | Am J Kidney Dis | View Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections | Health care providers | Clinical research |
Quality Control of Automated Cell Counters | Cembrowski GS, Clarke G | 2015 | Clin Lab Med | View Quality Control of Automated Cell Counters | Health care providers | Other |
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D | 2013 | Intensive Care Med | View Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Health care providers | Clinical research |
Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma | Hannon JL, Clarke G | 2015 | Transfusion | View Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma | Health care providers | Clinical research |
Use of cytomegalovirus (CMV) seronegative blood products | Ryan J | 2017 | Blood.ca website | View Use of cytomegalovirus (CMV) seronegative blood products | Health care providers | Benchmarking and standard setting |
Vein to Vein: A Summary of the Blood System in Canada | Chargé S | 2019 | Clinical Guide to Transfusion | View Vein to Vein: A Summary of the Blood System in Canada | Health care providers | Benchmarking and standard setting |
Troubles de l'hémostase et angioedéme héréditaire | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Troubles de l'hémostase et angioedéme héréditaire | Health care providers | Other |
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Iba T, Levy JH, Raj A, Warkentin TE | 2019 | J Clin Med | View Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Health care providers | Clinical research |
Rh System: Anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-Cw | Health care providers | Benchmarking and standard setting |
BSH guidelines for the use of irradiated blood components: guidance that is needed | Shehata N | 2020 | Br J Haematol | View BSH guidelines for the use of irradiated blood components: guidance that is needed | Health care providers | Benchmarking and standard setting |
Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Almizraq RJ, Branch DR | 2020 | Ann Blood | View Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Health care providers | Clinical research |
Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018 | Lewin A, Al Khan S, Beaudin L, Meilleur L, Clarke G, Richard L | 2020 | Vox Sang | View Report on the 19th International Society of Blood Transfusion Platelet Immunology Workshop 2018 | Health care providers | Benchmarking and standard setting |
Research Unit: A more accurate and efficient way to manage blood demand and supply | Li N | 2021 | Blood.ca website | View Research Unit: A more accurate and efficient way to manage blood demand and supply | Health care providers | New or improved product or process |
Heparin or nonheparin anticoagulants for VITT | Arnold DM | 2022 | Blood | View Heparin or nonheparin anticoagulants for VITT | Health care providers | Clinical research |
Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Kirpalani HM, Prokopchuk-Gauk O, Heddle NM | 2022 | JAMA Pediatr | View Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Health care providers | New or improved product or process |
FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Health care providers | New or improved product or process |
NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada | Quinn JG, Pavenski K, Webert K, Ye S | 2023 | National Advisory Committee on Blood and Blood Products | View NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada | Health care providers | Benchmarking and standard setting |
Tips, tricks, and thoughts on the future of prehospital blood transfusions | Yazer MH, Beckett A, Corley J, Devine DV, Studer NM, Taylor AL, Ward KR, Cap AP | 2022 | Transfusion | View Tips, tricks, and thoughts on the future of prehospital blood transfusions | Health care providers | Clinical research |
Acute Lung Injury Causes Asynchronous Alveolar Ventilation That Can Be Corrected by Individual Sighs | Tabuchi A, Nickles HT, Kim M, Semple JW, Koch E, Brochard L, Slutsky AS, Pries AR, Kuebler WM | 2015 | Am J Respir Crit Care Med | View Acute Lung Injury Causes Asynchronous Alveolar Ventilation That Can Be Corrected by Individual Sighs | Health care providers | Clinical research |
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Poglod R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH | 2018 | Transfusion | View An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Health care providers | Clinical research |
Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicentre cohort study | Peng J, Ma SH, Liu J, Hou Y, Liu XM, Niu T, Xu RR, Guo CS, Wang XM, Cheng YF, Ni H, Hou M | 2014 | J Thromb Haemost | View Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicentre cohort study | Health care providers | Clinical research |
Blood and clots quizlet 3: Procedures on warfarin | Tseng E, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 3: Procedures on warfarin | Health care providers | Benchmarking and standard setting |
Impact of amikacin on pseudothrombocytopenia | Bokaei PB, Grabovsky D, Shehata N, Wang C | 2017 | Acta Haematol | View Impact of amikacin on pseudothrombocytopenia | Health care providers | Clinical research |
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014 | Flegel WA, De Castilho SL, Keller MA, Klapper EB, Moulds JM, Noizat-Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA | 2015 | Blood Transfus | View Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014 | Health care providers | Other |
Perioperative Management of Dabigatran: A Prospective Cohort Study | Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M, Spencer FA, Solymoss S, Barty R, Wang G, Heddle N, Douketis JD | 2015 | Circulation | View Perioperative Management of Dabigatran: A Prospective Cohort Study | Health care providers | Clinical research |
Platelet transfusion, alloimmunization, and management of platelet refractoriness | Zeller M | 2016 | Clinical Guide to Transfusion | View Platelet transfusion, alloimmunization, and management of platelet refractoriness | Health care providers | Other |
The importance of iron for whole blood donors: a Canadian perspective | Pambrun C, Goldman M | 2017 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Other |
Albumin | Clarke G, Yan M | 2018 | Clinical Guide to Transfusion | View Albumin | Health care providers | Other |
McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A | 2018 | J Thromb Haemost | View McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Health care providers | Benchmarking and standard setting |
Group AB cryoprecipitate hospital practices | Romans R | 2019 | Blood.ca website | View Group AB cryoprecipitate hospital practices | Health care providers | Benchmarking and standard setting |
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussieres J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, FIBRES Research Group | 2019 | JAMA | View Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial | Health care providers | Clinical research |
Administration de produits sanguins | O'Reilly C | 2021 | Guide de la pratique transfusionnelle | View Administration de produits sanguins | Health care providers | Benchmarking and standard setting |
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies | Warkentin TE | 2020 | Hämostaseologie | View Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies | Health care providers | Clinical research |
COVID-19: Blood centres rise to the occasion and lead seroprevalence studies | Lieshout-Krikke RW, O'Brien SF, Saeed S, Lewin A | 2020 | Transfusion Today | Health care providers | Clinical research |